Cancel Preloader

Escherichia coli Vaccine Project

Vaccine Trial Centre: Escherichia coli Vaccine Project Timeline

2021

2022

2023

Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years (E.mbrace study: VAC52416BAC3001)

2024